Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Become the operational anchor and “second brain” to CIC’s Founder and Executive Chair. You will protect Tim’s time, preserve context, close loops, and help turn a remarkable range of relationships, ideas, and commitments into action. This